Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 1, 2016, Pages 157-169

  Pianta, Stefano ^a,b   Magatti, Marta ^a   Vertua, Elsa ^a   Bonassi Signoroni, Patrizia ^a   Muradore, Ivan ^a   Nuzzo, Anna Maria ^c   Rolfo, Alessandro ^c   Silini, Antonietta ^a   Quaglia, Federico ^a   Todros, Tullia ^c   Parolini, Ornella ^a  

^a Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Amniotic mesenchymal stromal cells; CTL; DC; Immunomodulation; Macrophage; Phenotype; Placenta; Pre eclampsia; T reg; Th

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 5; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; MESENCHYME CELL; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; AMNION; CASE CONTROL STUDY; CELL CULTURE; CELL POLARITY; COCULTURE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY; PREGNANCY; SECRETION (PROCESS);

AMNION; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL POLARITY; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FEMALE; HUMANS; IMMUNOMODULATION; MESENCHYMAL STROMAL CELLS; PRE-ECLAMPSIA; PREGNANCY; T-LYMPHOCYTES;

EID: 84956577092     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12715     Document Type: Article

References (59)

1. Egerman RS, Mercer BM, Doss JL, et al. A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. Am J Obstet Gynecol. 1998; 179: 1120-3.
2. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005; 308: 1592-4.
3. Boij R, Svensson J, Nilsson-Ekdahl K, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am J Reprod Immunol. 2012; 68: 258-70.
4. Borzychowski AM, Croy BA, Chan WL, et al. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol. 2005; 35: 3054-63.
5. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Goarzelak B, et al. The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol. 2002; 48: 381-6.
6. Toldi G, Rigo J Jr, Stenczer B, et al. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol. 2011; 66: 223-9.
7. Toldi G, Vasarhelyi ZE, Rigo J Jr, et al. Prevalence of regulatory T-cell subtypes in preeclampsia. Am J Reprod Immunol. 2015;Doi:10.1111/aji.12380.
8. Dong M, Wang Z, He J. Serum T helper 1- and 2-type cytokines in preeclampsia. Int J Gynaecol Obstet. 2005; 89: 288-90.
9. Dong M, He J, Wang Z, et al. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia. Acta Obstet Gynecol Scand. 2005; 84: 788-93.
10. Paeschke S, Chen F, Horn N, et al. Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am J Reprod Immunol. 2005; 54: 384-9.
11. + regulatory T lymphocytes in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand. 2008; 87: 190-4.
12. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol. 2012; 93: 75-81.
13. Prins JR, Boelens HM, Heimweg J, et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy. 2009; 28: 300-11.
14. Sacks GP, Redman CW, Sargent IL. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol. 2003; 131: 490-7.
15. van Nieuwenhoven AL, Moes H, Heineman MJ, et al. Cytokine production by monocytes, NK cells, and lymphocytes is different in preeclamptic patients as compared with normal pregnant women. Hypertens Pregnancy. 2008; 27: 207-24.
16. Faas MM, Spaans F, De Vos P. Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol. 2014; 5: 298.
17. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010; 63: 534-43.
18. Parolini O, Alviano F, Bergwerf I, et al. Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev. 2010; 19: 143-54.
19. + dendritic cells. Stem Cell Rev. 2015; 11: 423-41.
20. Abumaree MH, Al Jumah MA, Kalionis B, et al. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Rev. 2013; 9: 16-31.
21. Insausti CL, Blanquer M, Garcia-Hernandez AM, et al. Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application. Stem Cells Cloning. 2014; 7: 53-63.
22. Vacca P, Montaldo E, Vitale C, et al. MSC and innate immune cell interactions: a lesson from human decidua. Immunol Lett. 2015; pii: S0165-2478(15)00074-7.
23. Romani R, Pirisinu I, Calvitti M, et al. Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2, 3-dioxygenase1. J Cell Mol Med. 2015; 19: 1593-605.
24. Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells. 2008; 26: 300-11.
25. Marcus AJ, Woodbury D. Fetal stem cells from extra-embryonic tissues: do not discard. J Cell Mol Med. 2008; 12: 730-42.
26. Bailo M, Soncini M, Vertua E, et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004; 78: 1439-48.
27. Magatti M, De Munari S, Vertua E, et al. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells. 2008; 26: 182-92.
28. Wolbank S, Peterbauer A, Fahrner M, et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007; 13: 1173-83.
29. Rossi D, Pianta S, Magatti M, et al. Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS ONE. 2012; 7: e46956.
30. Pianta S, Bonassi Signoroni P, Muradore I, et al. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets. Stem Cell Rev. 2014; 11: 394-407. Doi:10.1007/s12015-014-9558-4.
31. Li J, Koike-Soko C, Sugimoto J, et al. Human amnion-derived stem cells have immunosuppressive properties on NK cells and monocytes. Cell Transplant. 2014; Doi:10.3727/096368914X685230.
32. Kronsteiner B, Peterbauer-Scherb A, Grillari-Voglauer R, et al. Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation. Cell Immunol. 2011; 267: 30-8.
33. Magatti M, Caruso M, De Munari S, et al. Human amniotic membrane-derived mesenchymal and epithelial cells exert different effects on monocyte-derived dendritic cell differentiation and function. Cell Transplant. 2015; 24: 1733-52.
34. Magatti M, De Munari S, Vertua E, et al. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 2009; 18: 899-914.
35. Castro EC, Reis MA, Teixeira VP. Thickening of the amnion basement membrane and its relationship to placental inflammatory lesions and fetal and maternal disorders. Eur J Obstet Gynecol Reprod Biol. 2004; 114: 171-6.
36. Correa RR, Guimaraes CS, Rocha LP, et al. Influence of inflammatory infiltrate and alterations of the blood flow in the etiopathogenesis of the basement membrane of the amniotic epithelium (BMAE) thickening in patients with hypertensive syndromes in pregnancy. Arch Gynecol Obstet. 2012; 286: 1117-21.
37. Rolfo A, Giuffrida D, Nuzzo AM, et al. Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia. PLoS ONE. 2013; 8: e59403.
38. Salic A, Mitchison TJ. A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci USA. 2008; 105: 2415-20.
39. Geginat J, Paroni M, Facciotti F, et al. The CD4-centered universe of human T cell subsets. Semin Immunol. 2013; 25: 252-62.
40. Geginat J, Paroni M, Maglie S, et al. Plasticity of human CD4 T cell subsets. Front Immunol. 2014; 5: 630.
41. + T cells expressing the FoxP3 transcription factor. Immunity. 2009; 30: 899-911.
42. + T cell differentiation during viral infection. Immunity. 2007; 27: 393-405.
43. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000; 18: 767-811.
44. Jacobs B, Wuttke M, Papewalis C, et al. Dendritic cell subtypes and in vitro generation of dendritic cells. Horm Metab Res. 2008; 40: 99-107.
45. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004; 25: 677-86.
46. Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G, et al. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology. 2006; 211: 487-501.
47. Hwang JH, Lee MJ, Seok OS, et al. Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies. Cytokine. 2010; 49: 95-101.
48. Portmann-Lanz CB, Baumann MU, Mueller M, et al. Neurogenic characteristics of placental stem cells in preeclampsia. Am J Obstet Gynecol. 2010; 203: 399 e1-7.
49. Espagnolle N, Guilloton F, Deschaseaux F, et al. CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. J Cell Mol Med. 2014; 18: 104-14.
50. Kronsteiner B, Wolbank S, Peterbauer A, et al. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev. 2011; 20: 2115-26.
51. Barboni B, Russo V, Curini V, et al. Gestational stage affects amniotic epithelial cells phenotype, methylation status, immunomodulatory and stemness properties. Stem Cell Rev. 2014; 10: 725-41.
52. Brandenburg S, Takahashi T, de la Rosa M, et al. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. Eur J Immunol. 2008; 38: 1643-53.
53. + regulatory T cell function. Eur J Immunol. 2004; 34: 2480-8.
54. Djurovic S, Schjetlein R, Wisloff F, et al. Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia. Clin Genet. 1997; 52: 371-6.
55. Shaarawy M, El Meleigy M, Rasheed K. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome. J Soc Gynecol Investig. 2001; 8: 27-31.
56. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, et al. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest. 1999; 103: 1641-50.
57. Todros T, Marzioni D, Lorenzi T, et al. Evidence for a role of TGF-beta1 in the expression and regulation of alpha-SMA in fetal growth restricted placentae. Placenta. 2007; 28: 1123-32.
58. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2011; 6: 457-78.
59. Murakami N, Riella LV. Co-inhibitory pathways and their importance in immune regulation. Transplantation. 2014; 98: 3-14.